110 related articles for article (PubMed ID: 32829108)
21. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
Zhu Z; Hou Q; Guo H
Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
[TBL] [Abstract][Full Text] [Related]
22. [Expressions of hypoxia inducible factor-1alpha and insulin-like growth factor-II in gastric carcinoma: correlation with angiogenesis and prognosis].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):905-8. PubMed ID: 17953839
[TBL] [Abstract][Full Text] [Related]
23. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
[TBL] [Abstract][Full Text] [Related]
25. Cyclooxygenase-2 expression and angiogenesis in colorectal cancer.
Xiong B; Sun TJ; Yuan HY; Hu MB; Hu WD; Cheng FL
World J Gastroenterol; 2003 Jun; 9(6):1237-40. PubMed ID: 12800231
[TBL] [Abstract][Full Text] [Related]
26. Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti-angiogenic therapies.
Yin L; Li J; Ma D; Li D; Sun Y
Oncol Lett; 2020 May; 19(5):3558-3566. PubMed ID: 32269630
[TBL] [Abstract][Full Text] [Related]
27. The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer.
Joo YE; Sohn YH; Joo SY; Lee WS; Min SW; Park CH; Rew JS; Choi SK; Park CS; Kim YJ; Kim SJ
Korean J Intern Med; 2002 Dec; 17(4):211-9. PubMed ID: 12647634
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer.
Pyo JS; Son BK; Oh IH
Pathol Res Pract; 2018 Nov; 214(11):1848-1853. PubMed ID: 30244946
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
Kaio E; Tanaka S; Kitadai Y; Sumii M; Yoshihara M; Haruma K; Chayama K
Oncology; 2003; 64(1):61-73. PubMed ID: 12457033
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.
Kimura Y; Morohashi S; Yoshizawa T; Suzuki T; Morohashi H; Sakamoto Y; Koyama M; Murata A; Kijima H; Hakamada K
Mol Med Rep; 2016 Feb; 13(2):1551-7. PubMed ID: 26676225
[TBL] [Abstract][Full Text] [Related]
31. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
[TBL] [Abstract][Full Text] [Related]
32. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer.
Nakasaki T; Wada H; Shigemori C; Miki C; Gabazza EC; Nobori T; Nakamura S; Shiku H
Am J Hematol; 2002 Apr; 69(4):247-54. PubMed ID: 11921018
[TBL] [Abstract][Full Text] [Related]
33. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cyclooxygenase-2 and vascular endothelial growth factor in vascularization and lymph node metastasis of colorectal cancers with submucosal invasion.
Abe A; Fukui H; Fujii S; Fujita M; Mukawa K; Ichikawa K; Tomita S; Ono Y; Imai Y; Imura J; Kubota K; Fujimori T
J Gastroenterol Hepatol; 2007 Jul; 22(7):1071-7. PubMed ID: 17608853
[TBL] [Abstract][Full Text] [Related]
35. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance and prognostic implication of nuclear fatty acid-binding protein 4 expression in colorectal cancer.
Kim SH; Pyo JS; Son BK; Oh IH; Min KW
Pathol Res Pract; 2023 Sep; 249():154722. PubMed ID: 37591068
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological significance of SIRT1 expression in colorectal cancer: A systematic review and meta analysis.
Zu G; Ji A; Zhou T; Che N
Int J Surg; 2016 Feb; 26():32-7. PubMed ID: 26763348
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
40. Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance.
Tang D; Nagano H; Yamamoto H; Wada H; Nakamura M; Kondo M; Ota H; Yoshioka S; Kato H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Wakasa K; Monden M
Oncol Rep; 2006 Mar; 15(3):525-32. PubMed ID: 16465407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
